Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 1Neuroma 1

Interventions

Bupivacaine 3Lidocaine 2Botulinum Toxins, Type A 2Therapeutics 1Sodium Chloride 1Ralfinamide 1Radiofrequency Ablation 1Musculoskeletal Manipulations 1Methylprednisolone 1Lidoderm 1Injections 1Indocyanine Green 1Dry Needling 1Decompression 1Cryosurgery 1Cholecalciferol 1Bevacizumab 1Anesthetics, Local 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neuroma × Ralfinamide × Clear all
NCT01019824 2017-09-15

Efficacy and Safety of Ralfinamide in Patients With Chronic Neuropathic Low Back Pain

Newron Pharmaceuticals SPA

Phase 3 Completed
411 enrolled

Neuroma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡